Effects of CD437 on Cell Viability and Caspase Activation in Freshly Isolated APL Blasts
Time . | Treatment . | No. Viable Cells ×1,000 (% viability) . | DEVD-amc Hydrolytic Activity (Fluorescence Arbitrary Units) . |
---|---|---|---|
Patient 1 | |||
16 h | Control | 550 ± 85 | 8.3 ± 1.4 |
(97 ± 2) | |||
CD437 | 490 ± 62 | 11.1 ± 2.0 | |
(86 ± 6) | |||
68 h | Control | 502 ± 120 | 6.3 ± 3.9 |
(72 ± 11) | |||
CD437 | 160 ± 17* | 72.0 ± 20.1* | |
(58 ± 9) | |||
Patient 2 | |||
16 h | Control | 360 ± 87 | 2.5 ± 1.8 |
(88 ± 3) | |||
CD437 | 298 ± 26 | 10.7 ± 1.5* | |
(89 ± 2) | |||
84 h | Control | 324 ± 54 | 4.1 ± 1.0 |
(88 ± 2) | |||
CD437 | 136 ± 18* | 6.6 ± 1.3 | |
(56 ± 2)* |
Time . | Treatment . | No. Viable Cells ×1,000 (% viability) . | DEVD-amc Hydrolytic Activity (Fluorescence Arbitrary Units) . |
---|---|---|---|
Patient 1 | |||
16 h | Control | 550 ± 85 | 8.3 ± 1.4 |
(97 ± 2) | |||
CD437 | 490 ± 62 | 11.1 ± 2.0 | |
(86 ± 6) | |||
68 h | Control | 502 ± 120 | 6.3 ± 3.9 |
(72 ± 11) | |||
CD437 | 160 ± 17* | 72.0 ± 20.1* | |
(58 ± 9) | |||
Patient 2 | |||
16 h | Control | 360 ± 87 | 2.5 ± 1.8 |
(88 ± 3) | |||
CD437 | 298 ± 26 | 10.7 ± 1.5* | |
(89 ± 2) | |||
84 h | Control | 324 ± 54 | 4.1 ± 1.0 |
(88 ± 2) | |||
CD437 | 136 ± 18* | 6.6 ± 1.3 | |
(56 ± 2)* |
Cells (600,000/mL for patient 1 and 300,000/mL for patient 2) were treated for the indicated amount of time with CD437 (10−6mol/L). At the end of treatment, aliquots of the cultures were stained with erythrosin for the determination of the number of cells and their viability. Remaining cells were harvested, homogenized, and the extract was assayed for DEVD-amc hydrolytic activity. Each value represents the mean ± SD of three replicate cultures.
Statistically significant relative to control following the Student’st-test (P < .01).